708 related articles for article (PubMed ID: 17659004)
1. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
[TBL] [Abstract][Full Text] [Related]
2. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M
Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.
Bakis-Petsoglou S; Le Guay JL; Wittal R
Br J Dermatol; 2009 Oct; 161(4):910-7. PubMed ID: 19523170
[TBL] [Abstract][Full Text] [Related]
5. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
6. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
Fai D; Cassano N; Vena GA
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
[TBL] [Abstract][Full Text] [Related]
7. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
[TBL] [Abstract][Full Text] [Related]
8. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
[TBL] [Abstract][Full Text] [Related]
9. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
[TBL] [Abstract][Full Text] [Related]
10. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
[TBL] [Abstract][Full Text] [Related]
11. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156
[TBL] [Abstract][Full Text] [Related]
12. Polypodium leucotomos extract in atopic dermatitis: a randomized, double-blind, placebo-controlled, multicenter trial.
Ramírez-Bosca A; Zapater P; Betlloch I; Albero F; Martínez A; Díaz-Alperi J; Horga JF;
Actas Dermosifiliogr; 2012 Sep; 103(7):599-607. PubMed ID: 22560125
[TBL] [Abstract][Full Text] [Related]
13. Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial.
Verhaeghe E; Lodewick E; van Geel N; Lambert J
Dermatology; 2011; 223(4):343-8. PubMed ID: 22269666
[TBL] [Abstract][Full Text] [Related]
14. No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo.
Ada S; Sahin S; Boztepe G; Karaduman A; Kölemen F
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):79-83. PubMed ID: 15752125
[TBL] [Abstract][Full Text] [Related]
15. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
[TBL] [Abstract][Full Text] [Related]
16. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo.
Goktas EO; Aydin F; Senturk N; Canturk MT; Turanli AY
J Eur Acad Dermatol Venereol; 2006 May; 20(5):553-7. PubMed ID: 16684283
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
[TBL] [Abstract][Full Text] [Related]
18. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
19. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
Asawanonda P; Klahan SO
Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
[TBL] [Abstract][Full Text] [Related]
20. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo.
Kullavanijaya P; Lim HW
Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
